Wednesday, June 18, 2025
26
C
Bengaluru
My account
Get into your account.
Hot topics
Don’t Do Digital for the Sake of Doing Digital
Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness.
The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy.
Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
Is Your Field Force Sales Enabled? Are They Sales Ready?
Pankaj Gurusahani and Arun Subramanian, Co-founder of Enparadigm with...
Breaking Performance Barriers
Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai
IMS Health Market Reflection Report for July 2016
The Indian Pharmaceutical Market (IPM) was valued atRs. 10,025 crores in the month of July 2016 clocking a 14.7% growth over same period last year (SPLY). This was the first time ever the market crossed the 10,000 crore mark in a single month.
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
Hot topics
You can Lead People
Articles by K. Hariram, Vivek Hattangadi, Hanno Wolfram, Soham Wagh and Amit Jain
National Seminar on UCPMP
The seminar will help companies especially Product Management Teams and Sales Teams to understand their changing roles due to UCPMP. It will also bring clarity on strategies and promotional inputs including CME's, sampling, gifts etc.
Inspirational Frontline Leadership
The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.
Draft Pharma Policy
Get an in-depth view into the Draft Pharma Policy - MedicinMan does a deep dive with the President of Karnataka Drug and Pharmaceutical Manufacturers Association
What my Sabziwali taught me about the Internet, Mobile Health & Smartphones
It’s very common for a pharma professional having neighbors, friends and relatives to engage in conversation over medicines. One such conversation – a pleasant surprise – which intrigued me to dig deep into internet dynamics was one with the local roadside Sabziwali.
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma
https://www.pharmamanufacturing.com/articles/2011/095
A quiet but seismic shift is underway in global...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Newsletter
Get important news delivered directly to your inbox and stay connected!